Cite
Möbitz H, Machauer R, Holzer P, et al. Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach. ACS Med Chem Lett. 2017;8(3):338-343doi: 10.1021/acsmedchemlett.6b00519.
Möbitz, H., Machauer, R., Holzer, P., Vaupel, A., Stauffer, F., Ragot, C., Caravatti, G., Scheufler, C., Fernandez, C., Hommel, U., Tiedt, R., Beyer, K. S., Chen, C., Zhu, H., & Gaul, C. (2017). Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach. ACS medicinal chemistry letters, 8(3), 338-343. https://doi.org/10.1021/acsmedchemlett.6b00519
Möbitz, Henrik, et al. "Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach." ACS medicinal chemistry letters vol. 8,3 (2017): 338-343. doi: https://doi.org/10.1021/acsmedchemlett.6b00519
Möbitz H, Machauer R, Holzer P, Vaupel A, Stauffer F, Ragot C, Caravatti G, Scheufler C, Fernandez C, Hommel U, Tiedt R, Beyer KS, Chen C, Zhu H, Gaul C. Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach. ACS Med Chem Lett. 2017 Feb 14;8(3):338-343. doi: 10.1021/acsmedchemlett.6b00519. eCollection 2017 Mar 09. PMID: 28337327; PMCID: PMC5346981.
Copy
Download .nbib